Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency
  5. Endocrinology

Endocrinology

  • Benign Prostatic Hypertrophy (11)
  • Cystitis (3)
  • Drug-Induced Nephrotoxicity (89)
  • Drug Use in Renal Insufficiency (200)
    • Bone/Joint and Rheumatology (19)
    • Cardiology (86)
    • Endocrinology (41)
    • Gastroenterology (19)
    • Hematology/Oncology (4)
    • Infectious Diseases (47)
    • Men's Health (1)
    • Neurology/Psychiatry (15)
    • Women's Health (2)
  • Hyperkalemia (12)
  • Hypokalemia (1)
  • Hyponatremia (4)
  • Incontinence (2)
  • Kidney Disease (34)
  • Kidney Stones (11)
  • Nephrology (42)
  • Overactive Bladder (20)
  • Resources (58)
  • Urinary Retention (6)
  • UTIs (67)
  • Urine Drug Testing (10)
31 - 41 of 41 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
PL Voices: Gliptins and Cardiovascular Risk November 2013
Article: Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes November 2013
Article: how to manage antiplatelet therapy in patients already taking anticoagulants November 2013
Guideline: 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada June 2013
Article: Canadian guidelines will affect the way you manage diabetes patients and address the growing diabetes epidemic June 2013
Chart: Renal Dosing of Gliptins (DPP-4 Inhibitors) December 2012
Article: two new tablet strengths of Januvia (sitagliptin) December 2012
PL Voices: Managing Type 2 Diabetes in Elderly Patients November 2012
Article: About 25% of your patients over age 65 have type 2 diabetes November 2012
Article: new option for adjusting medications in adults with kidney disease October 2009
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2006
  • « Prev
  • 1
  • 2
  • 3
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved